Tejara Capital’s Integra LifeSciences IART Stock Holding History

Tejara Capital’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-193,313	Closed	-$1.82M	–	77
2026 Q1	$1.82M	Buy	193,313 +21,500	+13%	+$236K	0.6%	52
2025 Q4	$2.13M	Buy	171,813 +51,300	+43%	+$682K	0.5%	34
2025 Q3	$1.73M	Sell	120,513 -7,873	-6%	-$108K	0.9%	32
2025 Q2	$1.58M	Buy	128,386 +73,386	+133%	+$1.07M	0.73%	43
2025 Q1	$1.21M	Buy	+55,000	New	+$1.29M	0.47%	50

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Tejara Capital's IART Position: Q2 2026 in Review

Tejara Capital sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 193,313 shares — an estimated $1.82M sold.

Tejara Capital first reported a position in IART in Q1 2025 and held it in 5 quarters. The position peaked at $2.13M in Q4 2025. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Tejara Capital reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
Tejara Capital sold 193,313 Integra LifeSciences shares in Q2 2026, an estimated $1.82M.
Tejara Capital first reported a position in Integra LifeSciences in Q1 2025 and held it in 5 quarters.
Tejara Capital's Integra LifeSciences position peaked at $2.13M in Q4 2025.
212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Tejara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.